...
首页> 外文期刊>Critical reviews in toxicology >The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
【24h】

The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.

机译:具有多个小鼠器官的彗星试验:彗星试验的结果和致癌性与选自IARC专论和美国NTP致癌性数据库的208种化学物质的比较。

获取原文

摘要

The comet assay is a microgel electrophoresis technique for detecting DNA damage at the level of the single cell. When this technique is applied to detect genotoxicity in experimental animals, the most important advantage is that DNA lesions can be measured in any organ, regardless of the extent of mitotic activity. The purpose of this article is to summarize the in vivo genotoxicity in eight organs of the mouse of 208 chemicals selected from International Agency for Research on Cancer (IARC) Groups 1, 2A, 2B, 3, and 4, and from the U.S. National Toxicology Program (NTP) Carcinogenicity Database, and to discuss the utility of the comet assay in genetic toxicology. Alkylating agents, amides, aromatic amines, azo compounds, cyclic nitro compounds, hydrazines, halides having reactive halogens, and polycyclic aromatic hydrocarbons were chemicals showing high positive effects in this assay. The responses detected reflected the ability of this assay to detect the fragmentation of DNA molecules produced by DNA single strand breaks induced chemically and those derived from alkali-labile sites developed from alkylated bases and bulky base adducts. The mouse or rat organs exhibiting increased levels of DNA damage were not necessarily the target organs for carcinogenicity. It was rare, in contrast, for the target organs not to show DNA damage. Therefore, organ-specific genotoxicity was necessary but not sufficient for the prediction of organ-specific carcinogenicity. It would be expected that DNA crosslinkers would be difficult to detect by this assay, because of the resulting inhibition of DNA unwinding. The proportion of 10 DNA crosslinkers that was positive, however, was high in the gastrointestinal mucosa, stomach, and colon, but less than 50% in the liver and lung. It was interesting that the genotoxicity of DNA crosslinkers could be detected in the gastrointestinal organs even though the agents were administered intraperitoneally. Chemical carcinogens can be classified as genotoxic (Ames test-positive) and putative nongenotoxic (Ames test-negative) carcinogens. The Ames test is generally used as a first screening method to assess chemical genotoxicity and has provided extensive information on DNA reactivity. Out of 208 chemicals studied, 117 are Ames test-positive rodent carcinogens, 43 are Ames test-negative rodent carcinogens, and 30 are rodent noncarcinogens (which include both Ames test-positive and negative noncarcinogens). High positive response ratio (110/117) for rodent genotoxic carcinogens and a high negative response ratio (6/30) for rodent noncarcinogens were shown in the comet assay. For Ames test-negative rodent carcinogens, less than 50% were positive in the comet assay, suggesting that the assay, which detects DNA lesions, is not suitable for identifying nongenotoxic carcinogens. In the safety evaluation of chemicals, it is important to demonstrate that Ames test-positive agents are not genotoxic in vivo. This assay had a high positive response ratio for rodent genotoxic carcinogens and a high negative response ratio for rodent genotoxic noncarcinogens, suggesting that the comet assay can be used to evaluate the in vivo genotoxicity of in vitro genotoxic chemicals. For chemicals whose in vivo genotoxicity has been tested in multiple organs by the comet assay, published data are summarized with unpublished data and compared with relevant genotoxicity and carcinogenicity data. Because it is clear that no single test is capable of detecting all relevant genotoxic agents, the usual approach should be to carry out a battery of in vitro and in vivo tests for genotoxicity. The conventional micronucleus test in the hematopoietic system is a simple method to assess in vivo clastogenicity of chemicals. Its performance is related to whether a chemical reaches the hematopoietic system. Among 208 chemicals studied (including 165 rodent carcinogens), 54 rodents carcinogens do not induce micronuclei in mouse hematopoietic system d
机译:彗星试验是一种微凝胶电泳技术,用于检测单细胞水平的DNA损伤。当将该技术用于检测实验动物的遗传毒性时,最重要的优点是,无论有丝分裂活性的程度如何,都可以在任何器官中测量DNA损伤。本文的目的是总结选自国际癌症研究机构(IARC)第1、2A,2B,3和4组和美国国家毒理学的208种化学物质对小鼠八个器官的体内遗传毒性。程序(NTP)致癌性数据库,并讨论彗星测定在遗传毒理学中的实用性。烷基化剂,酰胺,芳族胺,偶氮化合物,环状硝基化合物,肼,具有反应性卤素的卤化物和多环芳烃是在该测定法中显示出高正效应的化学物质。所检测到的响应反映了该测定法检测由化学诱导的DNA单链断裂产生的DNA分子的片段的能力,以及从烷基化的碱基和庞大的碱加合物形成的碱不稳定位点衍生的片段的能力。表现出增加的DNA损伤水平的小鼠或大鼠器官不一定是致癌性的靶器官。相反,很少有靶器官不显示DNA损伤。因此,器官特异性遗传毒性对于预测器官特异性致癌性是必要的,但不足。可以预料,由于对DNA解链的抑制作用,DNA交联剂将难以通过该测定法检测。然而,在胃肠道粘膜,胃和结肠中,阳性的10种DNA交联剂的比例很高,而在肝和肺中则不到50%。有趣的是,即使在腹膜内给药,也可以在胃肠道器官中检测到DNA交联剂的遗传毒性。化学致癌物可分为遗传毒性(Ames试验呈阳性)和假定的非遗传毒性(Ames试验呈阴性)。 Ames试验通常用作评估化学遗传毒性的第一种筛选方法,并提供了有关DNA反应性的广泛信息。在研究的208种化学品中,有117种是Ames测试阳性的啮齿动物致癌物,有43种是Ames测试阴性的啮齿动物致癌物,有30种是啮齿类非致癌物(包括Ames测试阳性和阴性非致癌物)。彗星试验显示,啮齿类动物遗传毒性致癌物的阳性反应率高(110/117),而啮齿类动物非致癌物质的阴性反应率率高(6/30)。对于Ames试验阴性的啮齿动物致癌物,彗星试验中不到50%呈阳性,这表明检测DNA损伤的试验不适合鉴定非遗传毒性致癌物。在化学品的安全性评估中,重要的是要证明Ames测试阳性药物在体内没有遗传毒性。该测定法对啮齿动物遗传毒性致癌物的阳性反应率高,而对啮齿动物遗传毒性非致癌物的阴性反应率率高,这表明彗星测定法可用于评估体外遗传毒性化学物质的体内遗传毒性。对于已通过彗星测定法在多个器官中测试了体内遗传毒性的化学药品,已发表的数据与未发表的数据进行了汇总,并与相关的遗传毒性和致癌性数据进行了比较。因为很明显,没有一项单一的测试能够检测所有相关的遗传毒性剂,所以通常的方法应该是进行一系列的遗传毒性体外和体内测试。造血系统中的常规微核试验是评估化学物质体内致胶性的简单方法。其性能与化学物质是否到达造血系统有关。在研究的208种化学物质(包括165种啮齿动物致癌物)中,54种啮齿动物致癌物不会在小鼠造血系统中诱导微核。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号